• Revenue Cycle Management
  • COVID-19
  • Reimbursement
  • Diabetes Awareness Month
  • Risk Management
  • Patient Retention
  • Staffing
  • Medical Economics® 100th Anniversary
  • Coding and documentation
  • Business of Endocrinology
  • Telehealth
  • Physicians Financial News
  • Cybersecurity
  • Cardiovascular Clinical Consult
  • Locum Tenens, brought to you by LocumLife®
  • Weight Management
  • Business of Women's Health
  • Practice Efficiency
  • Finance and Wealth
  • EHRs
  • Remote Patient Monitoring
  • Sponsored Webinars
  • Medical Technology
  • Billing and collections
  • Acute Pain Management
  • Exclusive Content
  • Value-based Care
  • Business of Pediatrics
  • Concierge Medicine 2.0 by Castle Connolly Private Health Partners
  • Practice Growth
  • Concierge Medicine
  • Business of Cardiology
  • Implementing the Topcon Ocular Telehealth Platform
  • Malpractice
  • Influenza
  • Sexual Health
  • Chronic Conditions
  • Technology
  • Legal and Policy
  • Money
  • Opinion
  • Vaccines
  • Practice Management
  • Patient Relations
  • Careers

Don't panic in a down market

Article

The price of a stock I bought last month recently plunged 20 percent. I'm a new investor, and just thinking about this makes me anxious. What should I do?

The price of a stock I bought last month recently plunged 20 percent. I'm a new investor, and just thinking about this makes me anxious. What should I do?

Review your original reasons for buying the stock to see if they still pass muster. Maybe you overlooked a flaw or two that changes your overall assessment of the company's value and potential. If so, admit the goof and cut your loss by selling the stock now; holding on in hopes of an unlikely reversal just gives the problem a chance to compound. But if you still believe the company belongs in your portfolio, seize the opportunity to buy more shares at a bargain price. That's particularly wise if the plunge is due to a setback that's probably temporary, such as a disappointing earnings report or bad news that primarily affects a competitor but is unfairly tainting the entire industry.

Related Videos